Additionally, we discovered that VTX, an antidepressant known for its cognitive benefits in depression, notably counteracts the abnormal NLRP3 inflammasome expression, particularly in the dorsal hippocampus 24 h after LPS exposure, potentially via regulating NEK7 expression. This evidence concerns the gene NLRP3 and major depressive disorder.